HHS, NIH Launch Next-Generation UNIVERSAL Vaccine Platform

Generation Gold Standard.

Disclaimer

I personally do not advocate any process or procedure contained in any of my Blogs. Information presented here is not intended to provide legal or lawful advice, nor medical advice, diagnosis, treatment, cure, or prevent any disease. Views expressed are for educational purposes only.

Bill Gates helped get President Trump “super interested” in universal flu vaccine

Apr 30, 2018

Bill Gates was talking to President Trump in the Oval Office last month [March 2018] when the conversation turned to the notion of a universal flu vaccine — probably, as Gates recalled in an interview, “the longest conversation about universal flu vaccine that the president’s ever had.”

“You should associate yourself with American innovation. Wouldn’t you love to have the universal flu vaccine be something that really got kicked off and energized by you?” Gates recalled asking Trump. The idea fired up the President, who Gates described as ‘super interested’. Continues at https://www.statnews.com/2018/04/30/bill-gates-vaccine-trump-meeting/

Bill Gates donated $12 million to fund research for a universal flu vaccine

Bill Gates announced Friday, Apr 27, 2018 he will donate $12 million to fund research for a universal flu vaccine. https://thehill.com/blogs/blog-briefing-room/385337-bill-gates-donating-12-million-to-fund-research-for-a-universal-flu/

After meeting with Bill Gates, Trump transition team sidelines 2 key figures disclosing vaccine truth

Jan 20/25

Prominent individuals ousted who understand issues caused by vaccines.

https://www.ourgreaterdestiny.ca/p/after-meeting-with-bill-gates-trump

Department of Health and Human Services and National Institutes for Health announce development of next-generation, universal vaccine platform

May 01/25

This initiative represents a decisive shift toward transparency, effectiveness, and comprehensive preparedness, funding the NIH’s in-house development of universal influenza and coronavirus vaccines, including candidates BPL-1357 and BPL-24910. These vaccines aim to provide broad-spectrum protection against multiple strains of pandemic-prone viruses like H5N1 avian influenza and coronaviruses including SARS-CoV-2, SARS-CoV-1, and MERS-CoV.

“Our commitment is clear: every innovation in vaccine development must be grounded in gold standard science and transparency, and subjected to the highest standards of safety and efficacy testing,” said HHS Secretary Robert F. Kennedy, Jr.

The program realigns BARDA’s operations with its statutory mission under the Public Health Service Act—to prepare for all influenza viral threats, not just those currently circulating. [Biomedical Advanced Research and Development Authority].

“Generation Gold Standard is a paradigm shift,” said NIH Director Dr. Jay Bhattacharya. “It extends vaccine protection beyond strain-specific limits and prepares for flu viral threats – not just today’s, but tomorrow’s as well – using traditional vaccine technology brought into the 21st century.”

Generation Gold Standard, developed exclusively by NIH’s National Institute of Allergy and Infectious Diseases (NIAID):

• Recalibrates America’s pandemic preparedness. .

• Embodies efficient, transparent, and government-led research.

• Marks the future of vaccine development.

Clinical trials for universal influenza vaccines are scheduled to begin in 2026, with FDA approval targeted for 2029. The intranasal BPL-1357 flu vaccine, currently in advanced trials, is also on track for FDA review by 2029. Details at
https://www.hhs.gov/press-room/hhs-nih-announces-generation-gold-standard.html

Trump administration's universal flu vaccine project puzzles scientists

Rob Stein
May 13.25
Excerpts

The announcement surprised vaccine researchers, given the anti-vaccine stance of health officials like Health and Human Services Secretary Robert F. Kennedy Jr.

An old vaccine technology back in the spotlight

But Ross and other outside vaccine experts are mystified by many aspects of Generation Gold Standard.

First of all, the project plans to use an approach that would involve injecting people with a whole flu virus that has been killed with a chemical to render it harmless but is still capable of stimulating the immune system. Most vaccine experts consider the whole killed virus approach to be antiquated.

"We're going back to technology that was used 40, 50 years ago or more. So this is a little surprising to me why you would go backwards to this technology? It's a very old technology," Poland says. "This is what influenza vaccines in the 40s, 50s and 60s looked like."

Whole dead virus vaccines tend to produce more side effects, including high fevers and seizures that especially can frighten parents, Poland, Ross and others say.

"We have live attenuated nasal spray influenza vaccines. We have recombinant influenza vaccines. We have an mRNA-based influenza vaccine," Poland says. "So why would you put all your eggs in one basket?"

A pricey bet on a single approach

The price tag: $500 million, which is a huge amount, especially at a time when federal health research funding is being slashed. The money that was originally earmarked to help explore a variety of technologies for next-generation COVID-19 vaccines.

Another aspect that's raising eyebrows is the fact that the technology — called a "beta-propiolactone (BPL)-inactivated, whole-virus platform" — was developed by two NIH scientists — Dr. Matthew Memoli and Dr. Jeffery Taubenberger. Memoli was recently named principal deputy director of the NIH after serving as Trump's acting NIH director. Taubenberger was recently named acting director of the National Institute of Allergy and Infectious Diseases. Taubenberger holds a patent on the technology. In addition, the strategy was picked without independent, public review and based on very limited preliminary testing.

"The BPL platform is fully government-owned and NIH-developed," the announcement says. "This approach ensures radical transparency, public accountability, and freedom from commercial conflicts of interest."

Live links and more at https://www.npr.org/sections/shots-health-news/2025/05/13/nx-s1-5384934/trump-universal-flu-vaccine

Generation Gold Standard: Ushering in UNIVERSAL FLU VACCINE Spearheaded by Bill Gates

May 16.25

With a history of targeting developing countries with profit-driven vaccination programs, Gates’ involvement in this project warrants a closer look. The universal flu vaccine, if successful, could represent a lucrative market for pharmaceutical companies and billions in profit for Gates’ ventures. But the use of an antiquated whole-killed virus approach, abandoned decades ago for its side effects and inefficiency, demands scrutiny. Is the new HHS and Secretary Kennedy on the brink of a breakthrough, or are we rushing headfirst into another dangerous experiment that only drives influenza mutations further? Continues at https://lionessofjudah.substack.com/p/hhs-launches-generation-gold-standard

The PREP Act

Everyone is tasked to get educated about the illegality of EUA [Emergency Use Authorization] countermeasures marketed as safe and effective approved FDA vaccines, to see how universal flu and coronavirus vaccines are extensions of an evil PREP Act playbook.
https://www.ourgreaterdestiny.ca/p/the-prep-act-repeal-is-an-uphill

Without prejudice and without recourse
Doreen Agostino
Our Greater Destiny Blog
vaccine